|
Aug 1
|
Apellis Pharmaceuticals (APLS) Surges 17.6% on Higher Price Target
|
|
Aug 1
|
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
|
|
Aug 1
|
Switzerland, the land of luxury brands, could see prices skyrocket from Trump's 39% tariffs
|
|
Aug 1
|
Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
|
|
Aug 1
|
Trump Unleashes Massive Tariffs on Swiss Watches, Pharma Firms
|
|
Aug 1
|
Trump doubles down on Most Favored Nation plan to target drug prices
|
|
Jul 31
|
Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
|
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs
|
|
Jul 31
|
Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook
|
|
Jul 31
|
Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
|
|
Jul 31
|
Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
|
|
Jul 31
|
Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer
|
|
Jul 31
|
Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health
|
|
Jul 31
|
Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON
|
|
Jul 31
|
Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health
|
|
Jul 29
|
INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
|
|
Jul 29
|
Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival
|
|
Jul 28
|
HS market forecast to reach $7.8bn across 7MM by 2034
|
|
Jul 28
|
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|